[HTML][HTML] Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma
T Nosaka, H Matsuda, R Sugata, Y Akazawa… - Current …, 2023 - mdpi.com
Background: Proton beam therapy (PBT) has been recently reported to achieve excellent
tumor control with minimal toxicity in patients with unresectable hepatocellular carcinoma …
tumor control with minimal toxicity in patients with unresectable hepatocellular carcinoma …
Prognostic Role of Albumin-Bilirubin Grade in Hepatocellular Carcinoma After Ultrasound-guided Percutaneous Radiofrequency Ablation: A Single-center Experience …
H Long, X Xie, G Huang, T Huang… - Surgical Laparoscopy …, 2022 - journals.lww.com
Background: The albumin-bilirubin (ALBI) grade has been proposed to evaluate liver
function and predict prognosis in patients with hepatocellular carcinoma (HCC). Data are …
function and predict prognosis in patients with hepatocellular carcinoma (HCC). Data are …
[HTML][HTML] Using period analysis to Timely assess and predict 5-Year relative survival for Liver Cancer Patients from Taizhou, Eastern China
Y Wang, L Zhang, F Han, R Li, Y Cheng, X Jiang… - Frontiers in …, 2022 - frontiersin.org
Introduction While timely assessment of long-term survival for patients with liver cancer is
essential for the evaluation of early detection and screening programs of liver cancer, those …
essential for the evaluation of early detection and screening programs of liver cancer, those …
[HTML][HTML] A Blood Hepatocellular Carcinoma Signature Recognizes Very Small Tumor Nodules with Metastatic Traits
K Chen, J Wang, L Jiang, F Zhao… - Journal of Clinical …, 2024 - xiahepublishing.com
Methods Data from HCC patients treated between 2010 and 2017 were retrospectively
collected. A blood signature for metastatic HCC was established based on blood levels of …
collected. A blood signature for metastatic HCC was established based on blood levels of …
[HTML][HTML] Percutaneous radiofrequency ablation combined with chemotherapy versus chemotherapy only for ovarian cancer liver metastasis
CX Wu, ML Chen, H Zhang, JJ Han - Frontiers in Oncology, 2022 - frontiersin.org
Purpose To compare the feasibility and efficacy of radiofrequency ablation (RFA) combined
with chemotherapy and chemotherapy alone in patients with ovarian cancer liver metastasis …
with chemotherapy and chemotherapy alone in patients with ovarian cancer liver metastasis …
儿童口呼吸诊断及对牙颌面发育的影响
郑阳山， 袁学顺， 姜晶， 邱书奇， 石照辉 - 中国口腔颌面外科杂志, 2024 - cjoms.org
上气道阻塞可导致口呼吸, 其在儿童中发病率较高. 儿童早期是牙颌面的快速发育期,
长期口呼吸会造成儿童牙颌面畸形及睡眠呼吸障碍, 严重危害儿童健康. 口呼吸需要耳鼻咽喉科 …
长期口呼吸会造成儿童牙颌面畸形及睡眠呼吸障碍, 严重危害儿童健康. 口呼吸需要耳鼻咽喉科 …
[HTML][HTML] Clinical outcomes of ablation compared with resection for single hepatocellular carcinoma lesions, as a primary treatment or bridging to Liver transplantation …
Background Ablative therapies (AT) are widely utilized as bridging treatment for liver
transplantation (LT) candidates with hepatocellular carcinoma (HCC) who are on the …
transplantation (LT) candidates with hepatocellular carcinoma (HCC) who are on the …
Are all local tumour progressions of HCC related to thermal ablation? A study of the causes and classification of local tumour progression
W Ding, S Liu, F Liu, Z Cheng, X Yu, Z Han, J Yu… - European …, 2022 - Springer
Objectives Local tumour progression (LTP) is believed to be a negative consequence of
imperfect thermal ablation, but we wondered if all LTP is truly due to imperfect ablation …
imperfect thermal ablation, but we wondered if all LTP is truly due to imperfect ablation …
[HTML][HTML] Effect of perfluorobutane microbubbles on radiofrequency ablation for hepatocellular carcinoma: suppression of steam popping and its clinical implication
Objective To evaluate the effect of perfluorobutane microbubbles (Sonazoid®, GE
Healthcare) on steam popping during radiofrequency (RF) ablation for treating …
Healthcare) on steam popping during radiofrequency (RF) ablation for treating …
[HTML][HTML] Report from the 21st Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; 20–21 September 2019
The 21st annual Western Canadian Gastrointestinal Cancer Consensus Conference
(WCGCCC) was held in Calgary, Alberta, 20–21 September 2019. The WCGCCC is an …
(WCGCCC) was held in Calgary, Alberta, 20–21 September 2019. The WCGCCC is an …